156 related articles for article (PubMed ID: 22145189)
21. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions.
Cunningham JK; Liu LM
Addiction; 2003 Sep; 98(9):1229-37. PubMed ID: 12930210
[TBL] [Abstract][Full Text] [Related]
22. Pharmacists on the front lines in the fight against meth. A 50-state comparison of the laws regulating the retail sale of pseudoephedrine.
Rigdon BA
J Leg Med; 2012 Apr; 33(2):253-83. PubMed ID: 22694096
[No Abstract] [Full Text] [Related]
23. Registration and reregistration application fees. Final rule; remanded for further notice and comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 1996 Dec; 61(251):68624-6. PubMed ID: 12192680
[TBL] [Abstract][Full Text] [Related]
24. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States.
Cunningham JK; Liu LM; Callaghan R
Addiction; 2009 Mar; 104(3):441-53. PubMed ID: 19207353
[TBL] [Abstract][Full Text] [Related]
25. Recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB). Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 Jan; 70(2):291-4. PubMed ID: 15630794
[TBL] [Abstract][Full Text] [Related]
26. Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Dec; 81(251):96992-7044. PubMed ID: 28068052
[TBL] [Abstract][Full Text] [Related]
27. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
[TBL] [Abstract][Full Text] [Related]
28. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
[TBL] [Abstract][Full Text] [Related]
29. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
[TBL] [Abstract][Full Text] [Related]
30. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Aug; 67(154):51987-52007. PubMed ID: 12194173
[TBL] [Abstract][Full Text] [Related]
31. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
Cunningham JK; Liu LM
Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
[TBL] [Abstract][Full Text] [Related]
32. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(144):43355-7. PubMed ID: 18949877
[TBL] [Abstract][Full Text] [Related]
33. DEA issues proposed rule on e-prescribing.
Ball FR
J Med Pract Manage; 2009; 24(4):243. PubMed ID: 19288650
[TBL] [Abstract][Full Text] [Related]
34. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
[TBL] [Abstract][Full Text] [Related]
35. Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2009 Apr; 74(64):15595-625. PubMed ID: 19507319
[TBL] [Abstract][Full Text] [Related]
36. Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Jul; 82(134):32457-61. PubMed ID: 28715162
[TBL] [Abstract][Full Text] [Related]
37. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
[TBL] [Abstract][Full Text] [Related]
38. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
Nonnemaker J; Engelen M; Shive D
Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
[TBL] [Abstract][Full Text] [Related]
39. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment.
Food and Drug Administration, HHS
Fed Regist; 2006 Jun; 71(114):34249-51. PubMed ID: 16795943
[TBL] [Abstract][Full Text] [Related]
40. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
